Trials / Not Yet Recruiting
Not Yet RecruitingNCT06079723
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
Analyzing the Patterns of Patient Engagement and Trends in Participation Observed in Medullary Thyroid Cancer Clinical Trials
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical studies, with a distinct emphasis on medullary thyroid cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications surpass conventional therapies, providing substantial evidence to endorse their broader adoption. The primary objective is to meticulously examine trial completion rates and voluntary withdrawals within this specific patient group. By actively participating in this observational study plays a critical role in pushing medical knowledge forward and advancing care for individuals suffering from the medullary thyroid cancer.
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2026-11-01
- First posted
- 2023-10-12
- Last updated
- 2023-10-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06079723. Inclusion in this directory is not an endorsement.